Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

China · Delayed Price · Currency is CNY

29.76

+0.41 (1.40%)

Sep 30, 2026, 3:00 PM CST

Market Cap	9.41B -27.9%
Revenue (ttm)	2.03B +10.5%
Net Income	237.42M -51.3%
EPS	0.75 -52.1%
Shares Out	316.05M
PE Ratio	39.50
Forward PE	n/a
Dividend	0.35 (1.18%)
Ex-Dividend Date	Jun 12, 2026

Volume	2,643,668
Open	29.58
Previous Close	29.35
Day's Range	29.35 - 29.93
52-Week Range	25.70 - 41.80
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHA:688076

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2009

Employees 2,360

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688076

Full Company Profile

Financial Performance

In 2025, SHA:688076's revenue was 1.94 billion, an increase of 19.57% compared to the previous year's 1.62 billion. Earnings were 332.42 million, a decrease of -17.80%.

Financial Statements